20 South Sarah Street St. Louis, MO 63108 314-615-6355 info@biogenerator.org


BioGenerator News

BacterioScan, a BioGenerator portfolio company, secures FDA clearance – UTI detection in hours, not days

May 14, 2018

St. Louis, May 14, 2018 – BacterioScan, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a 510(k) Premarket Notification clearance for its 216Dx Urinary Tract […]

Read More

BioGenerator Company RNAgri Inks Deal with Monsanto for Use of RNA Production Technology

Apr 04, 2018

BioGenerator-backed AgTech Company Focuses on Naturally-Occurring Process ST. LOUIS – RNAgri, a St. Louis startup developing technology for agriculture, has entered a research collaboration with global agriculture company Monsanto. The […]

Read More

St. Louis-based Unleash Immuno Oncolytics Attracts $3 Million Investment from Publicly-traded Japanese Company

Feb 19, 2018

BioGenerator-supported Company to Advance Cancer Therapies ST. LOUIS – St. Louis-based startup Unleash Immuno Oncolytics, which has developed viral-based biologics to attack cancerous tumors, has attracted a major investment from […]

Read More

SentiAR Awarded $2.2 Million Federal Grant to Advance Augmented Reality Cardiac Hologram Research

Feb 12, 2018

ST. LOUIS – A panel of cardiologists, engineers, and other experts have given SentiAR, Inc.’s augmented reality (AR) platform an exceptional peer review, leading the National Institutes for Health (NIH) […]

Read More

BioGenerator Wins Federal Grant to Build New St. Louis Bioscience Companies

Sep 26, 2017

ST. LOUIS – BioGenerator, the investment arm of BioSTL, has won a $300,000 grant from the U.S. Department of Commerce to capitalize on its retooled investment strategy. That strategy is […]

Read More

BioGenerator supported startup Disarm Therapeutics announces $30M financing

Sep 19, 2017

BioGenerator supported startup company Disarm Therapeutics has closed a $30M financing led by top tier venture funds including Atlas Ventures. Prior to the company being formed, BioGenerator supported the academic […]

Read More

BioGenerator Company Cofactor Genomics Announces $18M Series-A Round to Bring RNA to Precision Medicine

Sep 18, 2017

SAN FRANCISCO — Cofactor Genomics, developer of a leading platform for RNA sequencing and expression analysis, today announced $18M in financing led by Menlo Ventures with major participation from existing […]

Read More

BioGenerator Co-Leads Seed Round for Washington University Company SentiAR

Sep 12, 2017

ST. LOUIS – SentiAR, Inc. has closed a $1.1M Seed Round to accelerate its work to revolutionize the operating room with augmented reality software designed to improve visualization in cardiac […]

Read More

BioGenerator Company Confluence Life Sciences Acquired By Aclaris Therapeutics

Aug 08, 2017

ST. LOUIS –BioGenerator’s largest investment in any single company is paying off for St. Louis. Confluence Life Sciences, Inc. has been acquired by Aclaris Therapeutics, Inc. (NASDAQ: ACRS) for the […]

Read More

BioGenerator Supported Startup Precision Virologics Receives Investment From Oncolys BioPharma

Mar 29, 2017

Precision Virologics, a startup based on technology from Washington University, was created with support from BioGenerator Grants and BioSTL Fundamentals.  BioGenerator Grant funding supported laboratory proof of concept, grant applications […]

Read More

Latest Tweets

Getting Started

Entrepreneurs Investors